Topics:

COPD

COPD

A new study shows that the risk of chronic obstructive pulmonary disease increases with obesity. Yet, the risk was increased in underweight persons as well.

While high-dose opioids may be deadly, lower doses may be safe for symptom reduction in severe respiratory disease. For those with milder COPD, a new treatment is in testing.

High doses of N-acetylcysteine improve small airway function in patients with COPD. The unresolved question is why.

For patients with asthma or COPD, PL554 has the potential to both reverse bronchodilation and reduce inflammation more quickly and with fewer adverse effects.

Patients respond to 5 days of corticosteroid therapy just as well as to 14 days of therapy, according to a study.

Emphysematous cholecystitis is a rare condition that is the result of infection with Clostridium perfringens and other gas-producing organisms including Escherichia coli, Bacteroides fragilis, and Klebsiella species.

Older patients with chronic obstructive pulmonary disease are at higher risk for plaque formation in the carotid artery, increasing their risk of stroke.

Pages

Subscribe to COPD on [sitename]
Please Wait 20 seconds or click here to close